Stress echocardiogaphy: a useful test for assessing cardiac risk in diabetes
- PMID: 19436664
- PMCID: PMC2672453
Stress echocardiogaphy: a useful test for assessing cardiac risk in diabetes
Abstract
Cardiovascular disease is the leading cause of death in patients with diabetes therefore prompt diagnosis and treatment of high risk groups is essential. Dobutamine stress echocardiography is a safe, cheap and reliable method for coronary artery disease diagnosis and provides important long term prognostic information. The diagnostic accuracy and prognostic power of this technique has been validated by a number of studies on patients with and without diabetes. This article discusses the application, interpretation, and accuracy of stress echocardiography both in the general population and in patients with diabetes. The role of advanced imaging modalites such as myocardial contrast agents and tissue Doppler imaging is also explored.
Keywords: cardiovascular risk; diabetes; dobutamine stress echocardiography; ischemia.
Figures
References
-
- Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979;59:8–13. - PubMed
-
- Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434–44. - PubMed
-
- Heyndrickx C, Baic H, Nelkins P. Depression of regional blood flow and wall thickening after brief coronary occlusion. Am J Physiol. 1978;234:H653–60. - PubMed
-
- Picano E, Mathias W, Jr, Pingitore A, et al. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet. 1994;344:1190–2. - PubMed
